ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
INNATE PHARMA: ifrs:CashFlowsFromUsedInOperatingActivities
One fact, its scope and the complete path back to the official record.
Reported value
-32.559M{"amount": -32559000.0}- Entity
- INNATE PHARMA
- Metric
- ifrs:CashFlowsFromUsedInOperatingActivities
- Period
- 2023-01-01 – 2023-12-31
- Status
- superseded
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:9695002Y8420ZB8HJE29:2024-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:19:24.905918+02:00
Raw response SHA-256
c477e47ed4a27d7e67bbe48f2d843a4d…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.